Your search returned 19 results.

Sort
Results
1.
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23475636
Year: 2013
Citation:
  • Oncologist. 18(3):257-64, 2013.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
2.
ASCO's approach to a learning health care system in oncology. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 23942494
Year: 2013
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 9(3):145-8, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Hauser RS, Hudis CA, Lichter AS, Mann JT, Sledge GW, Swain SM, Yu PM
3.
What currently defines a breast center? Initial data from the national accreditation program for breast centers. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23814526
Year: 2013
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 9(2):e62-70, 2013 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burgin C, Granville T, Kaufman C, Moran MS, Swain S, Winchester DP
4.
Adjuvant trastuzumab: does time really matter?. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23624497
Year: 2013
Citation:
  • Oncologist. 18(5):490-2, 2013.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Swain SM
5.
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23940225
Year: 2013
Citation:
  • Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
6.
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24262440
Year: 2013
Citation:
  • Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
7.
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23685835
Year: 2013
Citation:
  • Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
8.
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23969513
Year: 2013
Citation:
  • Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
9.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23602601
Year: 2013
Citation:
  • Lancet Oncology. 14(6):461-71, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
10.
Drug discount program. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24129471
Year: 2013
Citation:
  • JAMA. 310(15):1626-7, 2013 Oct 16.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Swain SM, Ward JC
11.
Insights from the cancer center business summit: preparing for the future. Foreword. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23814510
Year: 2013
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 9(2):69, 2013 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Introductory Journal Article
Form of publication:
  • Journal Article
All authors:
  • Swain SM
12.
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 23530718
Year: 2013
Citation:
  • Expert Opinion on Biological Therapy. 13(5):779-90, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • O'Sullivan CC, Swain SM
13.
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24095300
Year: 2013
Citation:
  • Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
14.
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23634285
Year: 2013
Citation:
  • Cancer Medicine. 2(2):178-84, 2013 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Intramural
Form of publication:
  • Journal Article
All authors:
  • Ayed FB, Ayoub WB, Brown LM, Eissa S, Gail M, Kantor ED, Khalafallah S, Khaled H, Merajver S, Omar S, Schairer C, Soliman AS, Swain SM
15.
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
  • Swain, Sandra M
PMID:
  • 24129974
Year: 2013
Citation:
  • Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
16.
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23868905
Year: 2013
Citation:
  • Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
17.
Building bridges to conquer cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24043734
Year: 2013
Citation:
  • Journal of Clinical Oncology. 31(30):3731-6, 2013 Oct 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Addresses
  • Congresses
Form of publication:
  • Journal Article
All authors:
  • Swain SM
18.
Lessons learned from the development of the CancerLinQ prototype: Clinical decision support. MedStar authors:
  • Swain, Sandra M
PMID:
  • 28136264
Year: 2013
Citation:
  • Journal of Clinical Oncology. 31(31_suppl):237, 2013 Nov
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Hauser R, Hudis C, Lichter AS, Mann J, Sledge GW, Swain SM, Yu PP
19.
Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less Travelled. MedStar authors:
  • Swain, Sandra M
  • Veytsman, Irina
PMID:
  • 23302002
Year: 2013
Citation:
  • Current Molecular Pharmacology. 2013 Jan 08
Institution:
  • Washington Cancer Institute
Department:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Veytsman I, Aragon-Ching JB, Swain SM
Pages

Powered by Koha